IRVINE, CALIF. -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, announced that Dr. Ewen Chee, founder of Singapore’s leading aesthetic medical company Aesthetic Healthcare Holdings (“AHH”), has been appointed President of AHH and Lead Doctor for Asia Strategy at SBC Medical Group. In this role, Dr. Chee will support physician recruitment and training across the Asia-Pacific region, contributing to SBC’s global strategy.

Singapore is internationally recognized as a trusted destination for aesthetic medicine, supported by its robust medical infrastructure and stringent regulatory environment. Leveraging its geographic advantages, the country attracts patients from neighboring Indonesia, Malaysia, Thailand, and Vietnam, and has developed into a center of medical tourism, establishing itself as the “Aesthetic Medicine Hub of Asia.”

In this environment, Dr. Chee has accumulated more than 20 years of clinical experience and is regarded as a pioneer of aesthetic medicine in Singapore. In 1999, he founded The Chelsea Clinic, among the first to introduce IPL treatments domestically. He has served as an international trainer in various types of fillers, lasers, botulinum toxin, and thread lifts. In addition, he acted as Co-Chair of the Asia-Pacific Thread Lift Meeting (APEM), earning broad international recognition through education and speaking activities. Dr. Chee is also a certified physician of the American Academy of Aesthetic Medicine (AAAM), with his expertise presented at numerous international congresses and workshops.

Looking ahead, SBC will leverage Dr. Chee’s expertise and AHH’s brand portfolio to establish a scalable platform for physician recruitment and training across Asia-Pacific. Anchored by its group purpose, “Contributing to the happiness of people worldwide through medical innovation,” the Group is building a foundation for sustainable growth and expanding its leadership position in the global aesthetic medicine industry.